The tumor suppressor ING1 contributes to epigenetic control of cellular senescence

被引:29
|
作者
Abad, Maria [1 ]
Moreno, Alberto [1 ]
Palacios, Alicia [2 ]
Narita, Masako [4 ]
Blanco, Francisco [2 ,3 ]
Moreno-Bueno, Gema [1 ]
Narita, Masashi [4 ]
Palmero, Ignacio [1 ]
机构
[1] CSIC UAM, Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain
[2] CIC bioGUNE, E-48160 Derio, Spain
[3] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain
[4] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England
关键词
cellular senescence; chromatin; ING1; p53; histone marks; ONCOGENE-INDUCED SENESCENCE; HISTONE H3K4ME3 RECOGNITION; REPLICATIVE SENESCENCE; PLANT HOMEODOMAIN; GENOMIC STRUCTURE; CHROMATIN; GROWTH; P53; FIBROBLASTS; APOPTOSIS;
D O I
10.1111/j.1474-9726.2010.00651.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
P>Cellular senescence is an effective tumor-suppressive mechanism that causes a stable proliferative arrest in cells with potentially oncogenic alterations. Here, we have investigated the role of the p33ING1 tumor suppressor in the regulation of cellular senescence in human primary fibroblasts. We show that p33ING1 triggers a senescent phenotype in a p53-dependent fashion. Also, endogenous p33ING1 protein accumulates in chromatin in oncogene-senescent fibroblasts and its silencing by RNA interference impairs senescence triggered by oncogenes. Notably, the ability to induce senescence is lost in a mutant version of p33ING1 present in human tumors. Using specific point mutants, we further show that recognition of the chromatin mark H3K4me3 is essential for induction of senescence by p33ING1. Finally, we demonstrate that ING1-induced senescence is associated to a specific genetic signature with a strong representation of chemokine and cytokine signaling factors, which significantly overlaps with that of oncogene-induced senescence. In summary, our results identify ING1 as a critical epigenetic regulator of cellular senescence in human fibroblasts and highlight its role in control of gene expression in the context of this tumor-protective response.
引用
收藏
页码:158 / 171
页数:14
相关论文
共 50 条
  • [1] The tumor suppressor ING1 mediates cellular senescence through chromatin remodeling
    Soliman, M. A.
    Berardi, P.
    Feng, X.
    Colina, A.
    Young, D.
    Riabowol, K.
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2009, 87 (01): : 353 - 353
  • [2] The tumor suppressor ING1:: Structure and function
    Cheung, KJ
    Li, G
    EXPERIMENTAL CELL RESEARCH, 2001, 268 (01) : 1 - 6
  • [3] ING1 Tumor Suppressor Regulates Cellular Heat and Proteostatic Stress Response
    Thalappilly, S.
    Riabowol, K. T.
    MOLECULAR BIOLOGY OF THE CELL, 2013, 24
  • [4] ING1 and ING2: multifaceted tumor suppressor genes
    Claire Guérillon
    Delphine Larrieu
    Rémy Pedeux
    Cellular and Molecular Life Sciences, 2013, 70 : 3753 - 3772
  • [5] ING1 and ING2: multifaceted tumor suppressor genes
    Guerillon, Claire
    Larrieu, Delphine
    Pedeux, Remy
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2013, 70 (20) : 3753 - 3772
  • [6] Src Regulates the Activity of the ING1 Tumor Suppressor
    Yu, Lisa
    Thakur, Satbir
    Leong-Quong, Rebecca Y. Y.
    Suzuki, Keiko
    Pang, Andy
    Bjorge, Jeffrey D.
    Riabowol, Karl
    Fujita, Donald J.
    PLOS ONE, 2013, 8 (04):
  • [7] Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1)
    Garkavtsev, I
    Demetrick, D
    Riabowol, K
    CYTOGENETICS AND CELL GENETICS, 1997, 76 (3-4): : 176 - 178
  • [8] The ING1 tumour suppressor induces senescence via altering endocytosis
    Riabowol, K.
    Rajarajacholan, U. K.
    Thaalippilly, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S86 - S87
  • [9] Domain Recognition of the ING1 Tumor Suppressor by a Panel of Monoclonal Antibodies
    Suzuki, Keiko
    Boland, Donna
    Gong, Wei
    Riabowol, Karl
    HYBRIDOMA, 2011, 30 (03): : 239 - 245
  • [10] A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis
    Helbing, CC
    Veillette, C
    Riabowol, K
    Johnston, RN
    Garkavtsev, I
    CANCER RESEARCH, 1997, 57 (07) : 1255 - 1258